Nelson Anita L, Teal Stephanie B
Department of Obstetrics and Gynecology, David Geffen School of Medicine, Harbor-UCLA Medical Center, Torrance, California 90509-2910, USA.
Obstet Gynecol Surv. 2007 Apr;62(4):272-81. doi: 10.1097/01.ogx.0000259228.70277.6f.
An estimated 10%-30% of menstruating women experience menorrhagia at some time during their reproductive lives. Acute menorrhagia may present as an emergency requiring prompt medical or surgical intervention. Chronic menorrhagia affects a woman's quality of life in her work, family, and social interactions. Medical management is the first line of therapy for chronic menorrhagia. Agents that have been used to treat menorrhagia include iron, cyclooxygenase inhibitors, desmopressin, antifibrinolytics, gonadotropin-releasing hormone agonists, androgens, combined oral contraceptives, and progestins. Progestins can be administered systemically or locally and may be given cyclically or continuously. Increased use of effective medical therapies has the potential to reduce the number of surgical procedures, such as endometrial ablation and hysterectomy.